Atwood & Palmer’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.9K | Buy |
737
+178
| +32% | +$12.3K | ﹤0.01% | 240 |
|
|
2025
Q1 | $38.8K | Hold |
559
| – | – | ﹤0.01% | 241 |
|
|
2024
Q4 | $48.1K | Hold |
559
| – | – | ﹤0.01% | 221 |
|
|
2024
Q3 | $66.6K | Sell |
559
-22
| -4% | -$2.62K | ﹤0.01% | 207 |
|
|
2024
Q2 | $82.9K | Buy |
581
+181
| +45% | +$25.8K | 0.01% | 199 |
|
|
2024
Q1 | $51.4K | Hold |
400
| – | – | ﹤0.01% | 210 |
|
|
2023
Q4 | $41.4K | Buy |
400
+150
| +60% | +$15.5K | ﹤0.01% | 232 |
|
|
2023
Q3 | $22.7K | Buy |
+250
| New | +$22.7K | ﹤0.01% | 264 |
|
|
2017
Q4 | – | Sell |
-8,800
| Closed | -$212K | – | 300 |
|
|
2017
Q3 | $212K | Sell |
8,800
-1,300
| -13% | -$31.3K | 0.03% | 125 |
|
|
2017
Q2 | $217K | Sell |
10,100
-64,784
| -87% | -$1.39M | 0.03% | 122 |
|
|
2017
Q1 | $1.28M | Sell |
74,884
-327,852
| -81% | -$5.62M | 0.21% | 57 |
|
|
2016
Q4 | $7.22M | Sell |
402,736
-88,650
| -18% | -$1.59M | 1.3% | 28 |
|
|
2016
Q3 | $10.2M | Sell |
491,386
-1,380
| -0.3% | -$28.7K | 1.86% | 22 |
|
|
2016
Q2 | $13.3M | Buy |
492,766
+21,900
| +5% | +$589K | 2.39% | 17 |
|
|
2016
Q1 | $12.8M | Buy |
470,866
+470,036
| +56,631% | +$12.7M | 2.27% | 19 |
|
|
2015
Q4 | $24K | Hold |
830
| – | – | ﹤0.01% | 258 |
|
|
2015
Q3 | $23K | Buy |
830
+600
| +261% | +$16.6K | ﹤0.01% | 255 |
|
|
2015
Q2 | $6K | Buy |
+230
| New | +$6K | ﹤0.01% | 324 |
|